Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 12 | 2020 | 7702 | 0.590 |
Why?
|
| Motor Cortex | 2 | 2015 | 117 | 0.560 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 2013 | 49 | 0.550 |
Why?
|
| Ophthalmic Nerve | 1 | 2013 | 9 | 0.460 |
Why?
|
| Brain Neoplasms | 7 | 2020 | 4849 | 0.410 |
Why?
|
| Nose Neoplasms | 1 | 2013 | 229 | 0.380 |
Why?
|
| Spinal Diseases | 1 | 2011 | 125 | 0.380 |
Why?
|
| Glioma | 4 | 2015 | 1963 | 0.340 |
Why?
|
| Neurocytoma | 1 | 2008 | 17 | 0.340 |
Why?
|
| Cerebral Ventricles | 1 | 2008 | 98 | 0.320 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 5437 | 0.280 |
Why?
|
| Craniotomy | 3 | 2014 | 304 | 0.280 |
Why?
|
| Contrast Media | 5 | 2017 | 1472 | 0.260 |
Why?
|
| Pituitary Neoplasms | 2 | 2019 | 203 | 0.250 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2017 | 272 | 0.240 |
Why?
|
| Thyroid Neoplasms | 3 | 2021 | 1866 | 0.220 |
Why?
|
| Wakefulness | 2 | 2014 | 150 | 0.220 |
Why?
|
| Osteoblastoma | 1 | 2022 | 15 | 0.210 |
Why?
|
| Osteoma, Osteoid | 1 | 2022 | 22 | 0.210 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2022 | 21 | 0.210 |
Why?
|
| Hypophysitis | 1 | 2021 | 10 | 0.200 |
Why?
|
| Adrenal Insufficiency | 1 | 2021 | 49 | 0.190 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2019 | 22 | 0.180 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 50 | 0.180 |
Why?
|
| Iodine Radioisotopes | 1 | 2021 | 371 | 0.180 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2020 | 158 | 0.170 |
Why?
|
| Hypothyroidism | 1 | 2021 | 204 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2021 | 7551 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2013 | 341 | 0.170 |
Why?
|
| Oncogenic Viruses | 1 | 2018 | 18 | 0.170 |
Why?
|
| Pericardium | 1 | 2019 | 157 | 0.160 |
Why?
|
| Bioprosthesis | 1 | 2019 | 167 | 0.160 |
Why?
|
| Mitral Valve | 1 | 2019 | 271 | 0.160 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2019 | 180 | 0.150 |
Why?
|
| Sternotomy | 1 | 2017 | 58 | 0.150 |
Why?
|
| Tumor Virus Infections | 1 | 2018 | 224 | 0.150 |
Why?
|
| Monitoring, Intraoperative | 4 | 2014 | 264 | 0.140 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2018 | 362 | 0.140 |
Why?
|
| Cerebral Veins | 1 | 2016 | 28 | 0.140 |
Why?
|
| Laser Therapy | 1 | 2020 | 411 | 0.140 |
Why?
|
| Tetralogy of Fallot | 1 | 2017 | 149 | 0.130 |
Why?
|
| Melanoma | 1 | 2013 | 5317 | 0.130 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 106 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 1 | 2019 | 386 | 0.130 |
Why?
|
| Hyperbilirubinemia | 1 | 2015 | 78 | 0.130 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 355 | 0.130 |
Why?
|
| Anilides | 1 | 2017 | 268 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 50 | 0.130 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 216 | 0.130 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2016 | 142 | 0.130 |
Why?
|
| Skull Base | 1 | 2016 | 199 | 0.120 |
Why?
|
| Adenoma | 1 | 2019 | 716 | 0.120 |
Why?
|
| Bilirubin | 1 | 2015 | 221 | 0.120 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 500 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2017 | 419 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 563 | 0.120 |
Why?
|
| Genes, bcl-1 | 1 | 2013 | 24 | 0.120 |
Why?
|
| Humans | 33 | 2022 | 261506 | 0.110 |
Why?
|
| Paraganglioma | 1 | 2015 | 170 | 0.110 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2013 | 27 | 0.110 |
Why?
|
| Angiogenic Proteins | 1 | 2013 | 37 | 0.110 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2015 | 422 | 0.110 |
Why?
|
| Pheochromocytoma | 1 | 2015 | 281 | 0.110 |
Why?
|
| Aged | 15 | 2020 | 70117 | 0.110 |
Why?
|
| Male | 20 | 2020 | 123000 | 0.100 |
Why?
|
| Intraoperative Complications | 1 | 2014 | 301 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 1763 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 3 | 2017 | 3976 | 0.100 |
Why?
|
| Middle Aged | 17 | 2020 | 86204 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2016 | 1529 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 3 | 2017 | 3981 | 0.100 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 172 | 0.100 |
Why?
|
| Adult | 15 | 2020 | 77950 | 0.100 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 489 | 0.090 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 186 | 0.090 |
Why?
|
| Central Nervous System Cysts | 1 | 2010 | 16 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 4757 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 10035 | 0.090 |
Why?
|
| Skin Neoplasms | 2 | 2017 | 4654 | 0.090 |
Why?
|
| Pyridines | 1 | 2017 | 1244 | 0.090 |
Why?
|
| Female | 19 | 2020 | 141928 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2011 | 245 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 1046 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 2576 | 0.090 |
Why?
|
| Indoles | 1 | 2015 | 1009 | 0.080 |
Why?
|
| Sella Turcica | 1 | 2008 | 24 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 2017 | 2054 | 0.080 |
Why?
|
| Parietal Lobe | 1 | 2008 | 66 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 500 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 713 | 0.080 |
Why?
|
| Adolescent | 8 | 2019 | 31252 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2008 | 187 | 0.080 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 1283 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 592 | 0.080 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 142 | 0.080 |
Why?
|
| Brain | 2 | 2013 | 4113 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2021 | 37905 | 0.070 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 1946 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2017 | 4078 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2019 | 16273 | 0.070 |
Why?
|
| Headache | 2 | 2021 | 163 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 1237 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2015 | 1823 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2009 | 403 | 0.070 |
Why?
|
| Histones | 1 | 2012 | 1466 | 0.070 |
Why?
|
| Young Adult | 7 | 2019 | 21445 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2015 | 2819 | 0.060 |
Why?
|
| Postoperative Complications | 3 | 2019 | 5542 | 0.060 |
Why?
|
| Time Factors | 4 | 2019 | 12926 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5178 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2014 | 426 | 0.050 |
Why?
|
| Mothers | 1 | 2005 | 410 | 0.050 |
Why?
|
| Disease Management | 2 | 2017 | 1052 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2017 | 833 | 0.050 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2021 | 156 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2022 | 4744 | 0.050 |
Why?
|
| Temporal Bone | 1 | 2022 | 102 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 526 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2020 | 32848 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 163 | 0.050 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 114 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 2979 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2022 | 406 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 14889 | 0.040 |
Why?
|
| Therapeutics | 1 | 2017 | 34 | 0.040 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 4844 | 0.040 |
Why?
|
| Wrist | 1 | 2017 | 26 | 0.040 |
Why?
|
| Buttocks | 1 | 2017 | 24 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 1162 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 749 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 29902 | 0.040 |
Why?
|
| Dermatofibrosarcoma | 1 | 2017 | 72 | 0.040 |
Why?
|
| Coinfection | 1 | 2018 | 189 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 317 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2017 | 159 | 0.040 |
Why?
|
| Mohs Surgery | 1 | 2017 | 98 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 703 | 0.030 |
Why?
|
| Child | 4 | 2022 | 29154 | 0.030 |
Why?
|
| Prothrombin Time | 1 | 2015 | 44 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 1301 | 0.030 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2017 | 155 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 699 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 2020 | 510 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 1226 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2017 | 12873 | 0.030 |
Why?
|
| Skull | 1 | 2017 | 231 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 2015 | 102 | 0.030 |
Why?
|
| Operative Time | 1 | 2015 | 217 | 0.030 |
Why?
|
| India | 1 | 2015 | 301 | 0.030 |
Why?
|
| Veins | 1 | 2016 | 157 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1239 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2015 | 46 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2016 | 195 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 4971 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2016 | 485 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 344 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 550 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2020 | 1411 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2016 | 588 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 2173 | 0.030 |
Why?
|
| Neoplasms | 1 | 2018 | 15193 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 6009 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2016 | 561 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14289 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2013 | 445 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 4892 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 1890 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 584 | 0.020 |
Why?
|
| Radiosurgery | 1 | 2020 | 1330 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2014 | 644 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 666 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 5539 | 0.020 |
Why?
|
| Nerve Compression Syndromes | 1 | 2010 | 30 | 0.020 |
Why?
|
| Optic Chiasm | 1 | 2010 | 40 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2017 | 1863 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2010 | 119 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2010 | 245 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2015 | 1274 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 621 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 13310 | 0.020 |
Why?
|
| Prognosis | 2 | 2016 | 21713 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6207 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2330 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2015 | 1589 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2008 | 660 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 9244 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10001 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 5673 | 0.020 |
Why?
|
| Pregnancy | 2 | 2010 | 7573 | 0.020 |
Why?
|
| Genome, Human | 1 | 2013 | 1869 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 4804 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 5047 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 2422 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 6869 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 3552 | 0.010 |
Why?
|
| United States | 1 | 2017 | 15433 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 13658 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 11965 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 17523 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8223 | 0.010 |
Why?
|